15 clinical trials registered, 11 recruiting. Interventions under study include drug therapy, other interventions, medical devices, and gene therapy. Pipeline includes 4 PHASE2, 4 PHASE1. Research is sponsored by a mix of industry and academic institutions.
23 publications have been identified in PubMed for T-cell large granular lymphocyte leukemia. Research spans Case Report / Case Series (48%), Basic Science / Preclinical (17%), and Review / Meta-Analysis (9%).
Favrin G (2026). [PMID: 42229081](https://pubmed.ncbi.nlm.nih.gov/42229081/). *Leuk Res*. [Other]
Hu N (2026). [PMID: 41577641](https://pubmed.ncbi.nlm.nih.gov/41577641/). *Thoracic cancer*. [Case Report / Case Series]
Upadhyayula BS (2026). [PMID: 41482347](https://pubmed.ncbi.nlm.nih.gov/41482347/). *Cancer genomics & proteomics*. [Basic Science / Preclinical]
Chaggar G (2026). [PMID: 41913969](https://pubmed.ncbi.nlm.nih.gov/41913969/). *Can J Neurol Sci*. [Case Report / Case Series]
Calabretto G (2025). [PMID: 40721648](https://pubmed.ncbi.nlm.nih.gov/40721648/). *Leukemia*. [Basic Science / Preclinical]
Gernert M (2025). [PMID: 39853385](https://pubmed.ncbi.nlm.nih.gov/39853385/). *Zeitschrift fur Rheumatologie*. [Review / Meta-Analysis]
Semenzato G (2025). [PMID: 39363880](https://pubmed.ncbi.nlm.nih.gov/39363880/). *Haematologica*. [Epidemiology / Natural History]
Nigro A (2025). [PMID: 40377873](https://pubmed.ncbi.nlm.nih.gov/40377873/). *Inflammopharmacology*. [Gene Therapy / Novel Therapeutics]
Kotsiafti A (2025). [PMID: 40831436](https://pubmed.ncbi.nlm.nih.gov/40831436/). *International journal of laboratory hematology*. [Case Report / Case Series]
El Asmar S (2025). [PMID: 41025032](https://pubmed.ncbi.nlm.nih.gov/41025032/). *Oxford medical case reports*. [Case Report / Case Series]
